The Termeer Foundation Announces the Class of 2023 Termeer Fellows.

2023-04-10

BOSTON--(BUSINESS WIRE)--The Termeer Foundation is proud to announce the Class of 2023 Termeer Fellows. The Henri Termeer Fellowship Program is named in honor of the late Henri Termeer, a visionary leader in the biotechnology industry and designed to support first time CEOs who are patient focused and working to meet an unmet need through innovative science and passion. The support of the Termeer Foundation includes mentoring, networking and professional development intended to facilitate connections, break down silos, strengthen skillsets and ultimately enable a diverse array of current and future healthcare leaders who bring much-needed solutions to patients. Termeer Fellows have access to a network of industry leaders and mentors, opportunities for in-person and virtual network building, as well as professional and leadership development programming provided by top executive coaches and leadership development consultants.

The Class of 2023 Termeer Fellows include: Afreen Allam, SiNON Nano Sciences; Alvaro Amorrortu, Mediphage Bioceuticals; Lavi Erisson, Gensaic; Natalie Galant, Paradox Immunotherapeutics; Michael Goldberg, SURGE Therapeutics; Robert Johnson, Adrestia Therapeutics; Parastoo Khoshakhlagh, GC Therapeutics; Jason Kralic, Tellus Therapeutics, Inc; Dan Mandell, GRO Biosciences; June Park, siRNAgen Therapeutics; Safia Rizvi, CILA Therapeutics; Nele Van Dessel, Ernest Pharmaceuticals; and Cinzia Silvestri, Bi/ond (Transatlantic Connections Award honoree). Information about the Class of 2023 can be found here.

“Since the Foundation's inception, the Henri Termeer Fellowship Program has focused on supporting and mentoring the next generation of biotech entrepreneurs. We have done this with a rigorous interview process to select Termeer Fellows each year that have the same values and passion to make a difference and carry forward Henri’s legacy. It is inspiring to know that we are impacting a new generation of life science leaders.” -Belinda Termeer, President, Co-Founder and Board Chair.

The Termeer Foundation congratulates the Class of 2023 Termeer Fellows and looks forward to supporting them as they continue to make significant contributions to healthcare and life sciences.

About the Termeer Foundation

The Termeer Foundation is a nonprofit organization working to connect the world of healthcare innovators until every patient has a cure. We build and support an ever-expanding network of biotech entrepreneurs, CEOs, academics, and other innovators because we believe that helping people succeed will ultimately help their innovations reach patients. Our support includes mentoring, networking, professional development, and financial grants intended to facilitate connections, break down silos, strengthen skillsets and ultimately enable a diverse array of current and future healthcare leaders who bring much-needed solutions to patients. Find out more about The Termeer Foundation and how you can support, engage with, and join our network at www.termeerfoundation.org or on LinkedIn @TermeerFoundation.

更多内容，请访问原始网站

文中所述内容并不反映新药情报库及其所属公司任何意见及观点，如有版权侵扰或错误之处，请及时联系我们，我们会在24小时内配合处理。

机构